Review Process

 

Editorial Excellence & Procedural Integrity

Workflow & Evaluation Protocols

The EPH International Journal of Medical and Health Science (IJMHS) operates a transparent and rigorous evaluation framework. Submissions are managed through a structured workflow to ensure all published research meets the highest international academic and ethical benchmarks.

1

Preliminary Editorial Review

Upon submission, manuscripts undergo an initial screening. The editorial office evaluates Scope Relevance (medical focus), Formatting Compliance (structural protocols), and Academic Integrity (originality and ethics).

2

Double-Blind Peer Review

Manuscripts meeting baseline standards proceed to double-blind evaluation. To ensure total impartiality, the identities of authors and reviewers remain concealed from each other throughout the review cycle.

3

Technical Quality Markers

Experts assess Methodological Rigor (validity of design), Scientific Merit (novel insights), and Ethical Compliance. Authors must demonstrate adherence to international clinical and reporting guidelines.

4

Editorial Decision

Based on expert reports, the Editor-in-Chief issues a formal decision: Accept, Reject, or Revision. Anonymized feedback is provided to help authors strengthen their scientific arguments.

5

Revision & Re-validation

For "Revision" outcomes, authors must address all reviewer concerns. The revised manuscript undergoes re-evaluation by the editorial board to ensure all technical and ethical requirements are satisfied.

6

Final Acceptance & Publication

Upon final validation, the article enters copyediting and professional layout. Published work is released under the CC BY 4.0 license, allowing for immediate global visibility and open-access impact.

Commitment to Open Science

This structured workflow ensures that all research disseminated through IJMHS is transparent, robust, and ethical. By following this standardized path, the journal maintains its reputation for excellence in the international medical community.